Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CYTO -- Ignore unavailable to you. Want to Upgrade?

To: Jim Oravetz who wrote (7835)	4/7/2000 12:33:00 PM
From: Jim Oravetz	Read Replies (1) \| Respond to of 8116

Cytogen Corp. (CYTO) is asking its shareholders to approve a proposal to increase the company's common stock available for issuance to 250 million shares from 89.6 million shares, according to a proxy statement filed Thursday with the Securities and Exchange Commission. The amount of Cytogen preferred stock would remain the same, at 5.4 million shares. Cytogen said in the filing that the increase would ensure that shares will be available, if needed, for issuance in connection with stock splits, acquisitions and other corporate purposes. Shareholders of record as of April 3 will be eligible to vote on the proposal at the company's annual meeting scheduled for May 16.